Arcadia Biosciences（NASDAQ:RKDA）报告本季度每股亏损$(2.98)，低于分析师一致预期的$(0.89)，差距达到234.83%。相比去年同期每股亏损$(2.10)，下降了41.9%。公司本季度报告的销售额为1.216百万美元，高于分析师一致预期的1.200百万美元，超出1.33%。相比去年同期777.000千美元，增长了56.50%。

以上内容来自Benzinga Earnings专栏，原文如下：

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.98) per share which missed the analyst consensus estimate of $(0.89) by 234.83 percent. This is a 41.9 percent decrease over losses of $(2.10) per share from the same period last year. The company reported quarterly sales of $1.216 million which beat the analyst consensus estimate of $1.200 million by 1.33 percent. This is a 56.50 percent increase over sales of $777.000 thousand the same period last year.